Chat with Peter Dusabimana
Immunologist and Vaccine Researcher
About Peter Dusabimana
In 2018, Peter Dusabimana led the first Rwandan-led clinical evaluation of a heat-stable typhoid conjugate vaccine in rural Eastern Province, bypassing cold-chain dependency by validating field-ready storage protocols at ambient temperatures up to 40°C for 14 days. His team’s work directly informed Rwanda’s 2021 national rollout strategy, making it the first African country to integrate thermostable formulations into routine immunization without refrigerated transport. Trained at the London School of Hygiene & Tropical Medicine and later heading immunogenicity testing at the Centre for Infectious Disease Research in Kigali, he insists that vaccine equity isn’t just about access, it’s about redesigning assays, adjuvants, and delivery systems for East African immune phenotypes shaped by endemic helminth exposure and nutritional gradients. He co-developed the Kigali Immunogenicity Scoring Framework, now adopted by three regional regulatory authorities to assess real-world antibody persistence in children under five.
Why Chat with Peter Dusabimana?
Peter Dusabimana is one of the most influential figures in Science & Technology. Through AI conversation, you can explore their ideas, ask questions you've always wondered about, and gain unique perspectives on immunologist and vaccine researcher topics. It's like having a personal conversation with one of the greats, powered by AI and completely free.
Start Your Conversation with Peter Dusabimana
Ask questions, explore ideas, and learn something new. Free with an account, and no card.
Chat with Peter Dusabimana NowCall Peter Dusabimana and talk out loud
You do not have to type. Call Peter Dusabimana and hear the answer in their own voice, in this browser, with nothing to install. Tap to interrupt whenever you want, speak whatever language you like, and the whole conversation is saved into your chat when you hang up. 20 minutes of calls free every 30 days when you sign in, no card.
Call Peter Dusabimana How calling worksConversation Starters
Not sure where to begin? Try asking Peter Dusabimana:
- “How did your typhoid vaccine stability trials change Rwanda's cold-chain policy?”
- “What does 'immune phenotype adaptation' mean for vaccine dosing in rural Rwanda?”
- “Can you walk me through the Kigali Immunogenicity Scoring Framework?”
- “Why did you prioritize mucosal immunity studies for respiratory viruses in Burundi refugee camps?”
